Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1970 1
1976 1
1978 2
1980 1
1989 1
1990 2
1991 3
1993 1
1994 1
1995 4
1996 1
2000 1
2001 1
2002 4
2003 2
2004 3
2005 5
2006 5
2007 9
2008 9
2009 3
2010 4
2011 19
2012 11
2013 7
2014 4
2015 7
2016 7
2017 14
2018 12
2019 14
2020 7
2021 11
2022 8
2023 3
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. Among authors: bell rb. N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. N Engl J Med. 2025. PMID: 40532178 Clinical Trial.
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).
Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Duvvuri U, O'Malley BW Jr, Ozer E, Thomas GR, Koch WM, Gross ND, Bell RB, Saba NF, Lango M, Méndez E, Burtness B. Ferris RL, et al. Among authors: bell rb. J Clin Oncol. 2022 Jan 10;40(2):138-149. doi: 10.1200/JCO.21.01752. Epub 2021 Oct 26. J Clin Oncol. 2022. PMID: 34699271 Free PMC article. Clinical Trial.
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL. Cohen EEW, et al. Among authors: bell rb. J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. J Immunother Cancer. 2019. PMID: 31307547 Free PMC article. Clinical Trial.
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Leidner R, Crittenden M, Young K, Xiao H, Wu Y, Couey MA, Patel AA, Cheng AC, Watters AL, Bifulco C, Morris G, Rushforth L, Nemeth S, Urba WJ, Gough M, Bell RB. Leidner R, et al. Among authors: bell rb. J Immunother Cancer. 2021 May;9(5):e002485. doi: 10.1136/jitc-2021-002485. J Immunother Cancer. 2021. PMID: 33963014 Free PMC article. Clinical Trial.
Zygoma reconstruction.
Markiewicz MR, Gelesko S, Bell RB. Markiewicz MR, et al. Among authors: bell rb. Oral Maxillofac Surg Clin North Am. 2013 May;25(2):167-201. doi: 10.1016/j.coms.2013.02.005. Oral Maxillofac Surg Clin North Am. 2013. PMID: 23642668 Review.
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer.
Burtness B, Flamand Y, Quon H, Weinstein GS, Mehra R, Garcia JJ, Kim S, O'Malley BW Jr, Ozer E, Ikpeazu C, Koch WM, Gross ND, Bell RB, Patel M, Lango MN, Morris LG, Smith R, Karakla D, Richmon JD, Holsinger FC, Ferris RL. Burtness B, et al. Among authors: bell rb. J Clin Oncol. 2025 Aug 10;43(23):2559-2565. doi: 10.1200/JCO-24-02550. Epub 2025 Jun 10. J Clin Oncol. 2025. PMID: 40493877 Clinical Trial.
Secondary Correction of Midface Fractures.
Chodroff J, Elias N, Whitcomb M, Vo C, Bell RB. Chodroff J, et al. Among authors: bell rb. Atlas Oral Maxillofac Surg Clin North Am. 2021 Mar;29(1):139-150. doi: 10.1016/j.cxom.2020.11.008. Epub 2020 Dec 13. Atlas Oral Maxillofac Surg Clin North Am. 2021. PMID: 33516535 Review. No abstract available.
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy.
Saddawi-Konefka R, Msari RA, Tang S, Philips C, Sadat S, Clubb LM, Luna S, Fassardi S, Jones R, Pietryga IF, Faraji F, Schokrpur S, Yung BS, Allevato MM, Decker KE, Nasamran CA, Chilin-Fuentes D, Rosenthal SB, Jensen SM, Fox BA, Bell RB, Gutkind JS, Sharabi A, Califano JA. Saddawi-Konefka R, et al. Among authors: bell rb. Nat Commun. 2025 Jul 17;16(1):6578. doi: 10.1038/s41467-025-61780-4. Nat Commun. 2025. PMID: 40675962 Free PMC article.
Immunotherapy for Head and Neck Cancer.
Sim F, Leidner R, Bell RB. Sim F, et al. Among authors: bell rb. Hematol Oncol Clin North Am. 2019 Apr;33(2):301-321. doi: 10.1016/j.hoc.2018.12.006. Hematol Oncol Clin North Am. 2019. PMID: 30833002 Review.
174 results